Altech Batteries Ltd

ATC

Altech Batteries Ltd. is a specialty battery technology company, which engages in commercializing a solid-state sodium alumina battery production facility and developing battery materials for a Lithium-ion battery. The company is headquartered in Subiaco, Western Australia and currently employs 19 full-time employees. The company went IPO on 2010-01-27. The company has a joint venture agreement with the German battery institute Fraunhofer IKTS (Fraunhofer) to commercialize the CERENERGY Sodium Chloride Solid State (SCSS) Battery. CERENERGY batteries are an alternative to lithium-ion batteries. Its segments include Silumina Anodes, CERENERGY, and High Purity Alumina (HPA). Its Silumina Anodes project involves combining silicon and graphite and coating this composite product with a nanometer layer of high-purity alumina for inclusion in lithium battery anodes. CERENERGY batteries are fire and explosion-proof, have a life span of more than 15 years and operate in extreme cold and desert climates. The battery technology uses table salt and nickel, which is lithium-free; cobalt-free; graphite-free; and copper-free, eliminating exposure to critical metal price rises and supply chain concerns. The company is also engaged in the construction and operation of a 4,500tpa HPA processing plant.

Atomo Diagnostics Limited

AT1

Atomo Diagnostics Ltd. engages in manufacture, research, development, and design of in-vitro medical devices for blood-based rapid diagnostic testing (RDT) for professional use and self-testing. The firm supplies integrated rapid diagnostic test (RDT) devices to the global diagnostic market. The Company’s patented devices simplify testing procedures, enhance usability and improve reliability across rapid point-of-care (POC) and at-home testing applications. The firm has commercialized a number of products across international markets and has supply agreements in place for testing applications targeting infectious diseases, including COVID-19, HIV, viral vs bacterial differentiation and female health. Its products include Atomo HIV Self-Test, AtomoRapid HIV (1&2) and ATOMONOW Pregnancy Test. Its Atomo HIV Self-Test is an integrated, blood-based rapid diagnostic test (RDT) for HIV screening, which provides results in 15 minutes. Its AtomoRapid HIV (1&2) integrates multiple test components into the device platform. AtomoRapid HIV (1&2) needs a small drop of blood to give results in 15 minutes.

Atturra Limited

ATA

Atturra Ltd. engages in the provision of information technology solutions and services. The company is headquartered in Sydney, New South Wales and currently employs 800 full-time employees. The company went IPO on 2021-12-22. The firm is engaged in the technology business, providing a range of enterprise advisory, consulting, information technology (IT) services and solutions with a focus on local government, utilities, education, defense, federal government, financial services, and manufacturing industries. Its advisory and consulting capabilities across three areas include strategy and preparation, design and implementation, and realization and improvement. Its business applications capabilities include enterprise resource planning, process optimization for local government, payroll systems consulting, safety solutions, and others. Its data and integration capabilities include intelligent integration and automation, enterprise data management, advanced analytics, middleware modernization, and others. Its managed services include cloud and infrastructure, modern workplace, enterprise network services, and others.